MedTrace Logo

Psychosocial Risks in Liver Transplant Recipients

NCT02826460 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2016-07-11

No results posted yet for this study

Summary

A retrospective chart review in which the information in the standard psychosocial evaluations done pre-transplant for liver transplant recipients will be coded, recorded, and correlated with posttransplant outcomes of the same recipients. Evaluated outcomes include rejection episodes and adherence to tacrolimus, calculated through the MLVI (Medication Level Variability Index). The researchers will evaluate the degree to which both single elements in the evaluation as well as a cumulative score derived by a structured review of the chart using the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) model can predict posttransplant outcomes.

Conditions

  • End Stage Liver Disease

Sponsors & Collaborators

Principal Investigators

  • Eyal Shemesh, MD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02826460 on ClinicalTrials.gov